Comparison of postoperative outcomes in cases achieving sustained virological response with direct‐acting antiviral and interferon therapy

Abstract

AbstractBackground/PurposeThe effect of direct‐acting antiviral agents (DAAs) on hepatocellular carcinoma (HCC) recurrence after curative hepatectomy remains uncertain. This retrospective study aimed to evaluate the effect of sustained virological response (SVR) with DAAs or interferon (IFN) therapy on recurrence and overall survival (OS) after hepatectomy.MethodsWe enrolled 593 patients who underwent curative resections between January 2010 and December 2017. Among them, 186 achieved SVR before hepatectomy: a total of 51 (27.4%) in the DAA‐SVR group and 132 (72.6%) in the IFN‐based SVR group.ResultsSVR before hepatectomy was an independent predictor of OS, and the 5‐year OS rate was significantly higher in the SVR group than that in the non‐SVR group (82.2% vs. 63.9%). There were no significant differences in the recurrence rates or OS between DAA and IFN treatments in achieving SVR before hepatectomy, regardless of poor hepatic function in the DAA therapy group.ConclusionsThere was no significant difference in OS and recurrence‐free survival (RFS) between the preoperative SVR achieved with DAA and IFN groups in this study, although liver function was significantly worse at the time of surgery in the DAA group compared to the IFN group.